PhageTech is developing a diagnostic platform that uses bacteriophage substrates to detect disease-related analytes and protein biomarkers in urine, blood, and other bodily fluids
PhageTech is developing a diagnostic platform that uses bacteriophage substrates to detect disease-related analytes and protein biomarkers in urine, blood, and other bodily fluids. The platform is intended to improve sensitivity and stability while reducing testing costs, with demonstrated targets including PSMA and HSA relevant to prostate cancer and kidney disease.